Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc.

World Rank (Aug-2026)
2178
Market Cap (Aug-2026)
10.241 Billion USD
World Rank (Jan-05-2024)
17,121
Market Cap (Jan-05-2024)
0.232 Billion USD
World Rank (Jul-30-2023)
20,456
Market Cap (Jul-30-2023)
0.126 Billion USD
World Rank (Jan-07-2022)
10,597
Market Cap (Jan-07-2022)
0.812 Billion USD
World Rank (Jan-01-2021)
5,300
Market Cap (Jan-01-2021)
2.105 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
PRAX
Employee Count
139
Employee Count as of Date
As on 2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
0 Million USD
Annual Operating Income in USD
-326 Million USD
Annual Net Income in USD
-303 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
938 Million USD
Total Liabilities in USD
60 Million USD
Total Equity in USD
878 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Company Website
PRAXIS PRECISION MEDICINES, INC.
Yahoo
Yahoo @ Nasdaq
Company Profile
Praxis is a Clinical Stage Biopharmaceutical company translating genetic insights into the development of therapies for patients affected by central nervous system (“CNS”) disorders characterized by neuronal imbalance. The company annual net income is 35.5 million USD. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share